Out of Specification (OOS), Out of Trend (OOT), Out of Expectation (OOE)
Search Results

Enter a query to start searching.

Out of Specification (OOS), Out of Trend (OOT), Out of Expectation (OOE) NEW

This one-day training offers an in-depth overview of how to correctly handle OOS, OOT, and OOE results.

GMP & GDP training for pharma & biotech

  • Language:
    Dutch flag
  • 1 day in total

€ 997.00 ex. VAT

Registration ends in 451 days.

Register now!

This training contains:
  • Lunch
  • Digital copy of materials
  • Training certificate
  • What you will learn

    Name the applicable EU, MHRA and U.S. FDA regulatory requirements regarding OOS, OOT and OOE.

    To distinguish when there is an OOS, OOT, or OOE situation and which actions must be taken in each case.

    Form a correct hypothesis and root cause analysis when results are deviating.

    Better communication between the lab, QA and producten when dealing with OOS-investigations.

    Training Dates

    Dates Language Price Register
    9/29/26 to 9/29/26 Dutch spoken language (primary) € 997.00 Register

    Description

    The Training

    In the pharmaceutical industry, quality, safety, and efficacy are absolute requirements. Nevertheless, it is not uncommon for test results to fall outside of predefined specifications (OOS – Out Of Specification), deviate from expected trends (OOT – Out Of Trend), or exhibit unexpected behavior while still remaining within specifications (OOE – Out Of Expectation).

    Such deviations may indicate underlying quality issues and demand a thorough, structured, and well-substantiated approach.

    This one-day training offers an in-depth, practice-oriented overview of how OOS, OOT, and OOE results should be correctly identified, investigated, documented, and followed up on, in accordance with the expectations of authorities such as the IGJ, EMA, U.S. FDA, and MHRA. Through regulatory references, guidance documents, and real-life examples, you will learn how to manage OOS and OOT laboratory results effectively within your organization.

    The training includes interactive elements such as workshops, group discussions, and case studies based on real OOS reports. As a result, participants gain not only theoretical understanding but also practical insight for application in their daily work.

    Target Audience

    This training is intended for professionals in the pharmaceutical industry who are involved in laboratory investigations, quality control, or quality assurance, including roles in:

    • Quality Control (QC)

    • Quality Assurance (QA)

    • Regulatory Affairs

    • Production/Operations

    • Qualified Persons (QPs)

    • Contract Givers and Contract Laboratories

    Both junior and more experienced professionals involved in OOS/OOT investigations will benefit from this course.

    If you're a pharmacist or hospital pharmacist interested in earning accreditation points by attending this training,

    Results

    After completing the training, participants will be able to:

    • Describe the applicable European and U.S. regulations regarding OOS, OOT, and OOE (including Eudralex, FDA, MHRA).
    • Distinguish between OOS, OOT, and OOE results and know which actions are required in each case.
    • Understand the difference between Phase 1A, 1B, and Phase 2 investigations, and apply them appropriately.
    • Use effective hypothesis development and root cause analysis for abnormal results.
    • Set up and conduct a laboratory investigation effectively, including documentation aligned with inspector expectations.
    • Apply trend analysis, retesting, resampling, and outlier testing responsibly and scientifically.
    • Enhance communication and collaboration between QC, QA, and production departments during investigations.
    • Define and implement appropriate Corrective and Preventive Actions (CAPAs).
    • Make well-founded decisions on batch disposition in the case of confirmed or unconfirmed OOS results.

    Contents

    • Regulatory expectations for the QC laboratory
    • OOS regulations (EU GMP, MHRA, U.S. FDA)
    • Workshop
    • Process flow of an OOS
    • Workshop: Review an OOS
    • Latest guidance from the U.S. FDA
    • Workshop: Comment on an OOS
    • Processes and statistics
    • Workshop: A bright afternoon
    • Quiz

    Program

    Practical Information

    Difficulty / Level:
    Group discounts:
    • 2 participants - 5%
    • 3 participants - 10%
    • 4 participants - 15%
    • 4 participants - 20%
    • 6+ participants - 25%

    Group discounts are only applicable when multiple participants register for the same course at the same time.

    Language (upcoming edition):
    • nl flag Dutch spoken language (primary)
    • Some lectures/lessons may be in the secondary language. The primary language remains the dominant spoken/written language during the training.
    Learning form:
    Classroom
    Times:
    Starts at approx. 09:30 and ends at approx. 17:30

    Lecturer

    Eric van Wensveen avatar

    Eric van Wensveen

    Trainer

    Eric van Wensveen is a seasoned professional with over four decades of experience in the pharmaceutical industry, sp...

    training image

    € 997.00 ex. VAT

    Registration ends in 451 days.

    Register now!